Literature DB >> 17417123

Subarachnoid-pleural fistula in an infant treated with mechanical positive-pressure ventilation.

Frédéric V Valla1.   

Abstract

OBJECTIVE: To report a pediatric case of subarachnoid-pleural fistula, its diagnosis, and its treatment.
DESIGN: Case report.
SETTING: Pediatric intensive care unit. PATIENT: A 9-month-old boy, presenting with severe pleural effusion after posterior chest wall surgery.
INTERVENTIONS: Subarachnoid-pleural fistula was confirmed by isolating beta2-transferrin in the pleural fluid and with magnetic resonance cisternography revealing the location. The patient had a healthy outcome, and the fistula dried without surgery, using positive-pressure ventilation and a chest drain.
CONCLUSIONS: We used beta2-transferrin to confirm the diagnosis of clinically suspected subarachnoid-pleural fistula. High-resolution computed tomographic and magnetic resonance cisternography are the best techniques to localize the fistula. The currently recommended treatment is surgery; we suggest that bilevel positive-pressure ventilation, especially with noninvasive techniques, could be a treatment alternative, reducing the flow of cerebral spinal fluid through the fistula and allowing spontaneous closure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17417123     DOI: 10.1097/01.PCC.0000262800.57589.40

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  2 in total

1.  Diagnose and treatment of traumatic pleural-subarachnoid fistula in children: A case report and systematic review.

Authors:  Ming Ge; Qi Zeng; Wei Yang; Chenghao Chen
Journal:  Chin Neurosurg J       Date:  2020-08-06

2.  Subarachnoidal pleural fistula after resection of intradural thoracic disc herniation and multimodal treatment with noninvasive positive pressure ventilation (NPPV).

Authors:  Holger R Schlag; Samiul Muquit; Tanyo B Hristov; Guiseppe Morassi; Bronek Maximilian Boszczyk; Masood Shafafy
Journal:  Eur Spine J       Date:  2015-07-28       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.